| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64764-108-21 | 64764-108 | HUMAN PRESCRIPTION DRUG | ENTYVIO Pen | vedolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20230927 | N/A | BLA | BLA761133 | Takeda Pharmaceuticals America, Inc. | VEDOLIZUMAB | 108 mg/.68mL | 1 TRAY in 1 CARTON (64764-108-21) / 1 SYRINGE in 1 TRAY (64764-108-20) / .68 mL in 1 SYRINGE |
| 64764-107-11 | 64764-107 | HUMAN PRESCRIPTION DRUG | ENTYVIO | vedolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20230927 | N/A | BLA | BLA761133 | Takeda Pharmaceuticals America, Inc. | VEDOLIZUMAB | 108 mg/.68mL | 1 TRAY in 1 CARTON (64764-107-11) / 1 SYRINGE in 1 TRAY (64764-107-10) / .68 mL in 1 SYRINGE |